Serge Saxonov - 23 Aug 2021 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Executive Officer, Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact
Issuer symbol
TXG
Transactions as of
23 Aug 2021
Net transactions value
-$120,091
Form type
4
Filing time
25 Aug 2021, 20:38:36 UTC
Previous filing
04 Aug 2021
Next filing
09 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale $120,091 -742 -0.08% $161.85 903,326 23 Aug 2021 Direct F1
holding TXG Class A Common Stock 89,960 23 Aug 2021 See Footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2 The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.